Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannara Biotech Inc V.LOVE

Alternate Symbol(s):  LOVFF

Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.


TSXV:LOVE - Post by User

Comment by carmapon Jan 10, 2023 3:19pm
198 Views
Post# 35214128

RE:RE:RE:on va se faire passe une vite

RE:RE:RE:on va se faire passe une vite Albatros, excuse mon innocence, mais ou vois-tu un reverse-split 1:10 assur ici fin Janvier 2023 la-dedans?

Moi je vois une cie qui a remerci quelques  "insiders" et plus particulierement un qui s'est spcifiquement excellamment impliqu  en lui octroyant plus particulirement un bonus le 29-09-2022 par deux transactions, soit l'octroi de  7 500 000 et 12 500 000 droit d'achats.

Comme le volume n'est pas trs lev ces temps-ci, ils ont probablement dcid de racheter un montant quivalent pour ne pas faire tomber le cour et crer de la demande...

Peut-tre ai-je mes lunettes roses??

Carmap
<< Previous
Bullboard Posts
Next >>